A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy

The purpose of this literature review is to comprehensively summarize changes in the expression of phase II drug-metabolizing enzymes and drug transporters in both the pregnant woman and the placenta. Using PubMed<sup>®</sup>, a systematic search was conducted to identify literature rele...

Full description

Bibliographic Details
Main Authors: Christine Gong, Lynn N. Bertagnolli, David W. Boulton, Paola Coppola
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/15/11/2624
_version_ 1827639002628358144
author Christine Gong
Lynn N. Bertagnolli
David W. Boulton
Paola Coppola
author_facet Christine Gong
Lynn N. Bertagnolli
David W. Boulton
Paola Coppola
author_sort Christine Gong
collection DOAJ
description The purpose of this literature review is to comprehensively summarize changes in the expression of phase II drug-metabolizing enzymes and drug transporters in both the pregnant woman and the placenta. Using PubMed<sup>®</sup>, a systematic search was conducted to identify literature relevant to drug metabolism and transport in pregnancy. PubMed was searched with pre-specified terms during the period of 26 May 2023 to 10 July 2023. The final dataset of 142 manuscripts was evaluated for evidence regarding the effect of gestational age and hormonal regulation on the expression of phase II enzymes (<i>n</i> = 16) and drug transporters (<i>n</i> = 38) in the pregnant woman and in the placenta. This comprehensive review exposes gaps in current knowledge of phase II enzyme and drug transporter localization, expression, and regulation during pregnancy, which emphasizes the need for further research. Moreover, the information collected in this review regarding phase II drug-metabolizing enzyme and drug transporter changes will aid in optimizing pregnancy physiologically based pharmacokinetic (PBPK) models to inform dose selection in the pregnant population.
first_indexed 2024-03-09T16:31:39Z
format Article
id doaj.art-a96c35c23eea4e178c7fec153ecf8106
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T16:31:39Z
publishDate 2023-11-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-a96c35c23eea4e178c7fec153ecf81062023-11-24T15:01:10ZengMDPI AGPharmaceutics1999-49232023-11-011511262410.3390/pharmaceutics15112624A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during PregnancyChristine Gong0Lynn N. Bertagnolli1David W. Boulton2Paola Coppola3School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261, USAAstraZeneca LP, Biopharmaceuticals R&D, Clinical Pharmacology & Safety Sciences, Clinical Pharmacology & Quantitative Pharmacology, Gaithersburg, MD 20878, USAAstraZeneca LP, Biopharmaceuticals R&D, Clinical Pharmacology & Safety Sciences, Clinical Pharmacology & Quantitative Pharmacology, Gaithersburg, MD 20878, USAAstraZeneca LP, Biopharmaceuticals R&D, Clinical Pharmacology & Safety Sciences, Clinical Pharmacology & Quantitative Pharmacology, Cambridge CB2 0AA, UKThe purpose of this literature review is to comprehensively summarize changes in the expression of phase II drug-metabolizing enzymes and drug transporters in both the pregnant woman and the placenta. Using PubMed<sup>®</sup>, a systematic search was conducted to identify literature relevant to drug metabolism and transport in pregnancy. PubMed was searched with pre-specified terms during the period of 26 May 2023 to 10 July 2023. The final dataset of 142 manuscripts was evaluated for evidence regarding the effect of gestational age and hormonal regulation on the expression of phase II enzymes (<i>n</i> = 16) and drug transporters (<i>n</i> = 38) in the pregnant woman and in the placenta. This comprehensive review exposes gaps in current knowledge of phase II enzyme and drug transporter localization, expression, and regulation during pregnancy, which emphasizes the need for further research. Moreover, the information collected in this review regarding phase II drug-metabolizing enzyme and drug transporter changes will aid in optimizing pregnancy physiologically based pharmacokinetic (PBPK) models to inform dose selection in the pregnant population.https://www.mdpi.com/1999-4923/15/11/2624pregnancyplacentagestational changephase II enzymedrug transporterphysiologically based pharmacokinetic (PBPK) modeling
spellingShingle Christine Gong
Lynn N. Bertagnolli
David W. Boulton
Paola Coppola
A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy
Pharmaceutics
pregnancy
placenta
gestational change
phase II enzyme
drug transporter
physiologically based pharmacokinetic (PBPK) modeling
title A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy
title_full A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy
title_fullStr A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy
title_full_unstemmed A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy
title_short A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy
title_sort literature review of changes in phase ii drug metabolizing enzyme and drug transporter expression during pregnancy
topic pregnancy
placenta
gestational change
phase II enzyme
drug transporter
physiologically based pharmacokinetic (PBPK) modeling
url https://www.mdpi.com/1999-4923/15/11/2624
work_keys_str_mv AT christinegong aliteraturereviewofchangesinphaseiidrugmetabolizingenzymeanddrugtransporterexpressionduringpregnancy
AT lynnnbertagnolli aliteraturereviewofchangesinphaseiidrugmetabolizingenzymeanddrugtransporterexpressionduringpregnancy
AT davidwboulton aliteraturereviewofchangesinphaseiidrugmetabolizingenzymeanddrugtransporterexpressionduringpregnancy
AT paolacoppola aliteraturereviewofchangesinphaseiidrugmetabolizingenzymeanddrugtransporterexpressionduringpregnancy
AT christinegong literaturereviewofchangesinphaseiidrugmetabolizingenzymeanddrugtransporterexpressionduringpregnancy
AT lynnnbertagnolli literaturereviewofchangesinphaseiidrugmetabolizingenzymeanddrugtransporterexpressionduringpregnancy
AT davidwboulton literaturereviewofchangesinphaseiidrugmetabolizingenzymeanddrugtransporterexpressionduringpregnancy
AT paolacoppola literaturereviewofchangesinphaseiidrugmetabolizingenzymeanddrugtransporterexpressionduringpregnancy